Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Editorial (New Wave from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistr )
Volume: 12 Issue: 1
Author(s): Ryuichi Morishita
Affiliation:
Export Options
About this article
Cite this article as:
Morishita Ryuichi, Editorial (New Wave from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistr ), Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2012; 12 (1) . https://dx.doi.org/10.2174/187152212799857628
DOI https://dx.doi.org/10.2174/187152212799857628 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
13
Related Articles
-
Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Current Vascular Pharmacology The G Protein β3 Subunit Gene (GNB3) 825T Allele - a Thrifty Genotype
Current Genomics Cardiovascular Complications in Inflammatory Bowel Disease
Current Drug Targets Prostacyclin, Atherothrombosis, and Cardiovascular Disease
Current Medicinal Chemistry Treatment of Atopic Dermatitis: Current Status and Future Prospects
Current Drug Therapy Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis
Current Cardiology Reviews Targeting Resveratrol to Mitochondria for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
Current Vascular Pharmacology Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer’s Disease and Vascular Dementia
Current Alzheimer Research A Model on the Induction of Adverse Vascular Long-Term Effects of NSAIDs
Medicinal Chemistry Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy
Current Pharmacogenomics Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Current Pharmaceutical Design Beta-Blockers: Effects on Bone Mineral Density and Fracture Risk
Current Rheumatology Reviews Relaxin as a Cardiovascular Drug: A Promise Kept
Current Drug Safety IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Benefits of Resistance Training in Older Adults
Current Aging Science Vascular Dysfunction in Hypertensive Disorders
Current Hypertension Reviews Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Phenotypes of Obstructive Sleep Apnea and Direct Targeted Therapy: A Literature Review
Current Respiratory Medicine Reviews